Express Pharma

Eris Lifesciences Q4 22 revenues at Rs 3,059 million, up 10 per cent YoY

Revenue for Q4 FY22 grew by 10 per cent YoY to Rs 3,059 million, and for FY22 grew by 11.2 per cent YoY to Rs 13,470 million

0 178

Eris Lifesciences yesterd